 | • レポートコード：D0GIR-04928 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、エリスロポエチン治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。エリスロポエチン治療薬の種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他）、用途別市場規模（貧血、腎障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Biocon、Galenica、Johnson & Johnson、3SBio、Roche、Kyowa Hakko Kirin、Emcure、LG Life Sciences ・地域別グローバル市場分析 2015年-2020年 ・エリスロポエチン治療薬の北米市場（アメリカ、カナダ、メキシコ） ・エリスロポエチン治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・エリスロポエチン治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・エリスロポエチン治療薬の南米市場（ブラジル、アルゼンチン） ・エリスロポエチン治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他 ・用途別分析：貧血、腎障害、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Erythropoietin Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 10830 million by 2025, from USD 8727.6 million in 2019.
The Erythropoietin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Erythropoietin Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Erythropoietin Drug market has been segmented into
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
By Application, Erythropoietin Drug has been segmented into:
Anemia
Kidney Disorders
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Erythropoietin Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Erythropoietin Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Erythropoietin Drug market.
The report offers in-depth assessment of the growth and other aspects of the Erythropoietin Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Erythropoietin Drug Market Share Analysis
Erythropoietin Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Erythropoietin Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Erythropoietin Drug sales, revenue and market share for each player covered in this report.
The major players covered in Erythropoietin Drug are:
Amgen
Biocon
Galenica
Johnson & Johnson
3SBio
Roche
Kyowa Hakko Kirin
Emcure
LG Life Sciences
Among other players domestic and global, Erythropoietin Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erythropoietin Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erythropoietin Drug, with price, sales, revenue and global market share of Erythropoietin Drug in 2018 and 2019.
Chapter 3, the Erythropoietin Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erythropoietin Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Erythropoietin Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Erythropoietin Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Erythropoietin Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erythropoietin Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Erythropoietin Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.4 Overview of Global Erythropoietin Drug Market
1.4.1 Global Erythropoietin Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biocon
2.2.1 Biocon Details
2.2.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biocon SWOT Analysis
2.2.4 Biocon Product and Services
2.2.5 Biocon Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Galenica
2.3.1 Galenica Details
2.3.2 Galenica Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Galenica SWOT Analysis
2.3.4 Galenica Product and Services
2.3.5 Galenica Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 3SBio
2.5.1 3SBio Details
2.5.2 3SBio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 3SBio SWOT Analysis
2.5.4 3SBio Product and Services
2.5.5 3SBio Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Kyowa Hakko Kirin
2.7.1 Kyowa Hakko Kirin Details
2.7.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Kyowa Hakko Kirin SWOT Analysis
2.7.4 Kyowa Hakko Kirin Product and Services
2.7.5 Kyowa Hakko Kirin Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Emcure
2.8.1 Emcure Details
2.8.2 Emcure Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Emcure SWOT Analysis
2.8.4 Emcure Product and Services
2.8.5 Emcure Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 LG Life Sciences
2.9.1 LG Life Sciences Details
2.9.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 LG Life Sciences SWOT Analysis
2.9.4 LG Life Sciences Product and Services
2.9.5 LG Life Sciences Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Erythropoietin Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Erythropoietin Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Erythropoietin Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Erythropoietin Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Erythropoietin Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Erythropoietin Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Erythropoietin Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Erythropoietin Drug Sales and Growth Rate (2015-2020)
4.3 Europe Erythropoietin Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Erythropoietin Drug Sales and Growth Rate (2015-2020)
4.5 South America Erythropoietin Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Erythropoietin Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Erythropoietin Drug Sales, Revenue and Market Share by Country
5.1.1 North America Erythropoietin Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Erythropoietin Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Erythropoietin Drug Sales and Growth Rate (2015-2020)
5.3 Canada Erythropoietin Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Erythropoietin Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Erythropoietin Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Erythropoietin Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Erythropoietin Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Erythropoietin Drug Sales and Growth Rate (2015-2020)
6.3 UK Erythropoietin Drug Sales and Growth Rate (2015-2020)
6.4 France Erythropoietin Drug Sales and Growth Rate (2015-2020)
6.5 Russia Erythropoietin Drug Sales and Growth Rate (2015-2020)
6.6 Italy Erythropoietin Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Erythropoietin Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Erythropoietin Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Erythropoietin Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Erythropoietin Drug Sales and Growth Rate (2015-2020)
7.3 Japan Erythropoietin Drug Sales and Growth Rate (2015-2020)
7.4 Korea Erythropoietin Drug Sales and Growth Rate (2015-2020)
7.5 India Erythropoietin Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Erythropoietin Drug Sales and Growth Rate (2015-2020)
7.7 Australia Erythropoietin Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Erythropoietin Drug Sales, Revenue and Market Share by Country
8.1.1 South America Erythropoietin Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Erythropoietin Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Erythropoietin Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Erythropoietin Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Erythropoietin Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Erythropoietin Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Erythropoietin Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Erythropoietin Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Erythropoietin Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Erythropoietin Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Erythropoietin Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Erythropoietin Drug Sales and Market Share by Type (2015-2020)
10.2 Global Erythropoietin Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Erythropoietin Drug Price by Type (2015-2020)
11 Global Erythropoietin Drug Market Segment by Application
11.1 Global Erythropoietin Drug Sales Market Share by Application (2015-2020)
11.2 Global Erythropoietin Drug Revenue Market Share by Application (2015-2020)
11.3 Global Erythropoietin Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Erythropoietin Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Erythropoietin Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Erythropoietin Drug Market Forecast (2021-2025)
12.2.2 Europe Erythropoietin Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Erythropoietin Drug Market Forecast (2021-2025)
12.2.4 South America Erythropoietin Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Erythropoietin Drug Market Forecast (2021-2025)
12.3 Erythropoietin Drug Market Forecast by Type (2021-2025)
12.3.1 Global Erythropoietin Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Erythropoietin Drug Market Share Forecast by Type (2021-2025)
12.4 Erythropoietin Drug Market Forecast by Application (2021-2025)
12.4.1 Global Erythropoietin Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Erythropoietin Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Erythropoietin Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Erythropoietin Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Erythropoietin Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Erythropoietin Drug Major Business
Table 9. Amgen Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 10. Amgen SWOT Analysis
Table 11. Amgen Erythropoietin Drug Product and Services
Table 12. Amgen Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Erythropoietin Drug Major Business
Table 15. Biocon Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 16. Biocon SWOT Analysis
Table 17. Biocon Erythropoietin Drug Product and Services
Table 18. Biocon Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Galenica Basic Information, Manufacturing Base and Competitors
Table 20. Galenica Erythropoietin Drug Major Business
Table 21. Galenica Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 22. Galenica SWOT Analysis
Table 23. Galenica Erythropoietin Drug Product and Services
Table 24. Galenica Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Erythropoietin Drug Major Business
Table 27. Johnson & Johnson Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Erythropoietin Drug Product and Services
Table 30. Johnson & Johnson Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. 3SBio Basic Information, Manufacturing Base and Competitors
Table 32. 3SBio Erythropoietin Drug Major Business
Table 33. 3SBio Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 34. 3SBio SWOT Analysis
Table 35. 3SBio Erythropoietin Drug Product and Services
Table 36. 3SBio Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Roche Basic Information, Manufacturing Base and Competitors
Table 38. Roche Erythropoietin Drug Major Business
Table 39. Roche Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 40. Roche SWOT Analysis
Table 41. Roche Erythropoietin Drug Product and Services
Table 42. Roche Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 44. Kyowa Hakko Kirin Erythropoietin Drug Major Business
Table 45. Kyowa Hakko Kirin Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 46. Kyowa Hakko Kirin SWOT Analysis
Table 47. Kyowa Hakko Kirin Erythropoietin Drug Product and Services
Table 48. Kyowa Hakko Kirin Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Emcure Basic Information, Manufacturing Base and Competitors
Table 50. Emcure Erythropoietin Drug Major Business
Table 51. Emcure Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 52. Emcure SWOT Analysis
Table 53. Emcure Erythropoietin Drug Product and Services
Table 54. Emcure Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 56. LG Life Sciences Erythropoietin Drug Major Business
Table 57. LG Life Sciences Erythropoietin Drug Total Revenue (USD Million) (2018-2019)
Table 58. LG Life Sciences SWOT Analysis
Table 59. LG Life Sciences Erythropoietin Drug Product and Services
Table 60. LG Life Sciences Erythropoietin Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Erythropoietin Drug Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Erythropoietin Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Erythropoietin Drug Sales by Regions (2015-2020) (K Units)
Table 64. Global Erythropoietin Drug Sales Market Share by Regions (2015-2020)
Table 65. Global Erythropoietin Drug Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Erythropoietin Drug Sales by Countries (2015-2020) (K Units)
Table 67. North America Erythropoietin Drug Sales Market Share by Countries (2015-2020)
Table 68. North America Erythropoietin Drug Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Erythropoietin Drug Revenue Market Share by Countries (2015-2020)
Table 70. Europe Erythropoietin Drug Sales by Countries (2015-2020) (K Units)
Table 71. Europe Erythropoietin Drug Sales Market Share by Countries (2015-2020)
Table 72. Europe Erythropoietin Drug Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Erythropoietin Drug Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Erythropoietin Drug Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Erythropoietin Drug Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Erythropoietin Drug Sales by Countries (2015-2020) (K Units)
Table 77. South America Erythropoietin Drug Sales Market Share by Countries (2015-2020)
Table 78. South America Erythropoietin Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Erythropoietin Drug Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Erythropoietin Drug Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Erythropoietin Drug Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Erythropoietin Drug Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Erythropoietin Drug Revenue Market Share by Countries (2015-2020)
Table 84. Global Erythropoietin Drug Sales by Type (2015-2020) (K Units)
Table 85. Global Erythropoietin Drug Sales Share by Type (2015-2020)
Table 86. Global Erythropoietin Drug Revenue by Type (2015-2020) (USD Million)
Table 87. Global Erythropoietin Drug Revenue Share by Type (2015-2020)
Table 88. Global Erythropoietin Drug Sales by Application (2015-2020) (K Units)
Table 89. Global Erythropoietin Drug Sales Share by Application (2015-2020)
Table 90. Global Erythropoietin Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Erythropoietin Drug Market Share Forecast by Regions (2021-2025)
Table 92. Global Erythropoietin Drug Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Erythropoietin Drug Market Share Forecast by Type (2021-2025)
Table 94. Global Erythropoietin Drug Sales Forecast by Application (2021-2025)
Table 95. Global Erythropoietin Drug Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Erythropoietin Drug Picture
Figure 2. Global Sales Market Share of Erythropoietin Drug by Type in 2019
Figure 3. Epoetin-alfa Picture
Figure 4. Darbepoetin-alfa Picture
Figure 5. Epoetin-beta Picture
Figure 6. Others Picture
Figure 7. Erythropoietin Drug Sales Market Share by Application in 2018
Figure 8. Anemia Picture
Figure 9. Kidney Disorders Picture
Figure 10. Other Picture
Figure 11. Global Erythropoietin Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Erythropoietin Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Erythropoietin Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Erythropoietin Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Erythropoietin Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Erythropoietin Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Erythropoietin Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Erythropoietin Drug Revenue Market Share by Regions in 2018
Figure 40. North America Erythropoietin Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Erythropoietin Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Erythropoietin Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Erythropoietin Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Erythropoietin Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Erythropoietin Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Erythropoietin Drug Sales Market Share by Countries in 2018
Figure 48. North America Erythropoietin Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Erythropoietin Drug Revenue Market Share by Countries in 2018
Figure 50. United States Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Erythropoietin Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Erythropoietin Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Erythropoietin Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Erythropoietin Drug Revenue Market Share by Regions 2019
Figure 64. China Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Erythropoietin Drug Sales Market Share by Countries in 2019
Figure 71. South America Erythropoietin Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Erythropoietin Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Erythropoietin Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Erythropoietin Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Erythropoietin Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Erythropoietin Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Erythropoietin Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Erythropoietin Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Erythropoietin Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Erythropoietin Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Erythropoietin Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Erythropoietin Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Erythropoietin Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
エリスロポエチン（EPO）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Erythropoietin (EPO) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Erythropoietin (EPO) mar…- エリスロポエチン（EPO）治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Erythropoietin (EPO) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- EPOバイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global EPO Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The EPO Biomarkers market report p…
- 鎮痛剤デリバリーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pain Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pain Drug Delivery market …
- 薬物再プロファイリングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drug Reprofiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…